Gonorrhoea

The U.S. Food and Drug Administration (FDA) has recently approved two new oral medicines—Nuzolvence (zoliflodacin) and Blujepa (gepotidacin)—for the treatment of gonorrhoea, a common sexually transmitted infection (STI) that has shown increasing resistance to existing antibiotics. This approval marks a significant advancement in addressing antimicrobial-resistant gonorrhoea.

About Gonorrhoea

Gonorrhoea is a preventable and curable sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It is commonly referred to as “the clap” or “the drip.”
The infection can affect several parts of the body, including the urethra, rectum, female reproductive tract, mouth, throat, and eyes.

Transmission

Gonorrhoea is most commonly transmitted through vaginal, oral, or anal sexual contact with an infected person.
It can also be transmitted from mother to child during childbirth. In newborns, the infection most commonly affects the eyes, potentially leading to serious complications if untreated.

At-Risk Population

Gonorrhoea can affect people of any age, sex, or gender, but it is particularly common among adolescents and young adults aged 15 to 24 years.

Symptoms

Many individuals infected with gonorrhoea do not experience noticeable symptoms. When symptoms occur, they usually appear within 1 to 14 days after infection.

• Men are more likely to show symptoms.

• Up to 50% of women may remain asymptomatic.

Common symptoms include:

• Unusual vaginal or penile discharge

• Pain or burning during urination

• Pelvic or genital pain

• Sore throat (oral infection)

• Conjunctivitis (eye infection)

Complications of Untreated Gonorrhoea

If left untreated, gonorrhoea can lead to serious and long-term health complications, including:

• Pelvic inflammatory disease (PID)

• Infertility in both males and females

• Epididymitis and prostatitis in men

• Systemic infections affecting the skin, joints, heart (endocarditis), and brain (meningitis)

Some of these complications can cause permanent damage to health.

Prevention

Gonorrhoea can be prevented by:

• Practising safe sex, including the consistent use of condoms, and

• Regular screening and early treatment, especially among high-risk populations.

Treatment and Antimicrobial Resistance

Gonorrhoea is treatable and curable with antibiotics. However, antimicrobial resistance (AMR) has emerged as a serious global public health concern, making many traditional antibiotics ineffective and raising the risk of untreatable infections.

The recent FDA approval of new oral antibiotics represents a crucial step in combating drug-resistant gonorrhoea and strengthening global STI control efforts.

Conclusion

Gonorrhoea remains a significant public health challenge due to its high prevalence, asymptomatic nature, and growing drug resistance. The development of new effective treatments, along with preventive strategies and awareness, is essential to control the spread of this infection and prevent long-term health complications.